Cystatin A protease inhibitor and cysteine proteases in human cervicovaginal fluid in term pregnancy and labor.

Autor: Heng YJ, Di Quinzio MK, Permezel M, Rice GE, Georgiou HM

Publikováno v: American Journal of Obstetrics & Gynecology; Mar2011, Vol. 204 Issue 3, p254.e1-7, 1p

Extracellular vesicle-encapsulated miR-30c-5p reduces aging-related liver fibrosis.

Autor: Rodrigues AC; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Pharmacology, Universidade de Sao Paulo Instituto de Ciencias Biomedicas, São Paulo, Brazil., Heng YJ; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Slack FJ; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Aging cell [Aging Cell] 2024 Sep 13, pp. e14310. Date of Electronic Publication: 2024 Sep 13.

Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals.

Autor: Heng YJ; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Dana 517B, Boston, MA, 02115, USA. yheng@bidmc.harvard.edu., Baker GM; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Dana 517B, Boston, MA, 02115, USA., Fein-Zachary VJ; Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Guzman-Arocho YD; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Dana 517B, Boston, MA, 02115, USA., Bret-Mounet VC; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Dana 517B, Boston, MA, 02115, USA., Massicott ES; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Dana 517B, Boston, MA, 02115, USA., Torous VF; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Schnitt SJ; Dana-Farber/Brigham and Women's Cancer Center, Dana-Farber Cancer Institute-Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Gitin S; The Fenway Institute, Boston, MA, USA., Russo P; The Fenway Institute, Boston, MA, USA., Tobias AM; Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Bartlett RA; Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Varma G; Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Kontos D; Departments of Radiology, Biomedical Informatics, and Biomedical Engineering, Columbia University Irving Medical Center, New York, NY, USA., Yaghjyan L; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA., Irwig MS; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Potter JE; The Fenway Institute, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Wulf GM; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2024 Jul 02; Vol. 26 (1), pp. 109. Date of Electronic Publication: 2024 Jul 02.

Associations of stem cell markers CD44, CD24 and ALDH1A1 with mammographic breast density in women with benign breast biopsies.

Autor: Yaghjyan L; University of Florida, College of Public Health and Health Professions and College of Medicine, Department of Epidemiology, Gainesville, FL, USA. lyaghjyan@ufl.edu., Heng YJ; Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA., Baker GM; Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA., Murthy D; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Mahoney MB; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Rosner B; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Tamimi RM; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.

Publikováno v: British journal of cancer [Br J Cancer] 2024 Jul; Vol. 131 (2), pp. 325-333. Date of Electronic Publication: 2024 Jun 07.

Reciprocal antagonism of PIN1-APC/C ^CDH1 governs mitotic protein stability and cell cycle entry.

Autor: Ke S; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Dang F; Department of Pathology, Beth Israel Deaconess Medical Center and Cancer Research Institute, Harvard Medical School, Boston, MA, 02215, USA., Wang L; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Chen JY; Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, 02215, USA., Naik MT; Department of Molecular Biology, Cell Biology & Biochemistry, Brown University, Providence, RI, 02912, USA., Li W; Yale Cancer Biology Institute, West Haven, CT, 06516, USA., Thavamani A; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Kim N; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Naik NM; Department of Molecular Biology, Cell Biology & Biochemistry, Brown University, Providence, RI, 02912, USA., Sui H; Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University, Xiamen Medical College, Xiamen, 361023, China., Tang W; Data Science & Artificial Intelligence, R&D, AstraZeneca, Gaithersburg, MD, USA., Qiu C; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Genetics, Harvard Medical School, Boston, MA, 02115, USA., Koikawa K; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Batalini F; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Department of Medicine, Division of Medical Oncology, Mayo Clinic, Phoenix, AZ, USA., Stern Gatof E; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Isaza DA; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Patel JM; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Wang X; Molecular and Integrative Physiological Sciences, Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02215, USA., Clohessy JG; Preclinical Murine Pharmacogenetics Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Heng YJ; Department of Pathology, Beth Israel Deaconess Medical Center and Cancer Research Institute, Harvard Medical School, Boston, MA, 02215, USA., Lahav G; Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA., Liu Y; Yale Cancer Biology Institute, West Haven, CT, 06516, USA.; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, 06510, USA., Gray NS; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford University, Stanford, CA, 94305, USA., Zhou XZ; Departments of Pathology and Laboratory Medicine, Biochemistry, and Oncology, and Lawson Health Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 3K7, Canada. xzhou659@uwo.ca., Wei W; Department of Pathology, Beth Israel Deaconess Medical Center and Cancer Research Institute, Harvard Medical School, Boston, MA, 02215, USA. wwei2@bidmc.harvard.edu., Wulf GM; Division of Hematology/Oncology, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. gwulf@bidmc.harvard.edu., Lu KP; Departments of Biochemistry and Oncology, and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 3K7, Canada. klu92@uwo.ca.

Publikováno v: Nature communications [Nat Commun] 2024 Apr 15; Vol. 15 (1), pp. 3220. Date of Electronic Publication: 2024 Apr 15.